Exciting news to share from our affiliate company Biomimetic Innovations Ltd: BMI have signed an exclusive US license and distribution agreement and minority investment with Sanara MedTech (Nasdaq: SMTI). We look forward to working in #partnership with BMI and Sanara MedTech to bring #OsSticTechnology to #trauma patients in the US!
We are pleased to announce a new partnership at Biomimetic Innovations! BMI have signed an exclusive US license and distribution agreement (Trauma) and minority investment with Sanara MedTech (Nasdaq: SMTI). Sanara MedTech have acquired exclusive US marketing, sales, and distribution rights to OsStic® Synthetic Injectable Structural Bio-Adhesive Bone Void Filler, as well as a hardware agnostic adjunctive internal fixation technology to promote targeted delivery of OsStic® in fracture management. “Together, we look forward to bringing transformative solutions to market that enhance the surgeon’s treatment approach and improve patient outcomes.” -Paul Burke, Managing Partner of PBC Biomed and acting CEO of Biomimetic Innovations Ltd Click here to read more: https://lnkd.in/e4_GaeXC #acceleratingmedicalinnovation #osstictechnology #pbcbiomed #collaboration